| 12/06/25 | GSK | 11:00:00 | 12 Jun 2025 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 25/05/22 | GSK | 15:41:00 | 25 May 2022 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 01/12/21 | GSK | 11:05:00 | 1 Dec 2021 | | GSK | Total Voting Rights | GSK plc | PRN |
| 01/12/17 | | 13:47:25 | 1 Dec 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/12/17 | | 13:44:14 | 1 Dec 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/12/17 | | 13:37:40 | 1 Dec 2017 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 30/11/17 | | 07:00:02 | 30 Nov 2017 | | | ViiV starts Phase 3 HIV prevention study in women | GlaxoSmithKline PLC | RNS |
| 27/11/17 | | 14:03:04 | 27 Nov 2017 | | | ViiV starts Phase 3 longacting HIV treatment study | GlaxoSmithKline PLC | RNS |
| 23/11/17 | | 07:00:55 | 23 Nov 2017 | | | GSK submit IMPACT data to support Trelegy Ellipta | GlaxoSmithKline PLC | RNS |
| 22/11/17 | | 07:00:01 | 22 Nov 2017 | | | ViiV Juluca approved in US as first 2-drug regimen | GlaxoSmithKline PLC | RNS |
| 21/11/17 | | 14:21:53 | 21 Nov 2017 | | | GSK publishes 2018 dividend dates | GlaxoSmithKline PLC | RNS |
| 16/11/17 | | 07:00:02 | 16 Nov 2017 | | | Trelegy Ellipta EU approval for treatment of COPD | GlaxoSmithKline PLC | RNS |
| 10/11/17 | | 13:15:50 | 10 Nov 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 09/11/17 | | 17:00:31 | 9 Nov 2017 | | | Block listing Interim Review | GlaxoSmithKline PLC | RNS |
| 08/11/17 | | 14:00:03 | 8 Nov 2017 | | | Directorate Change | GlaxoSmithKline PLC | RNS |
| 08/11/17 | | 14:00:01 | 8 Nov 2017 | | | Directorate Change | GlaxoSmithKline PLC | RNS |
| 07/11/17 | | 15:01:40 | 7 Nov 2017 | | | US regulatory application for mepolizumab in COPD | GlaxoSmithKline PLC | RNS |
| 02/11/17 | | 07:35:47 | 2 Nov 2017 | | | BCMA receives FDA Breakthrough Therapy Designation | GlaxoSmithKline PLC | RNS |
| 01/11/17 | | 12:01:56 | 1 Nov 2017 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 01/11/17 | | 11:01:11 | 1 Nov 2017 | | | Superiority of Anoro Ellipta demonstrated for COPD | GlaxoSmithKline PLC | RNS |
| 25/10/17 | | 18:46:56 | 25 Oct 2017 | | | CDC ACIP makes recommendations for use of Shingrix | GlaxoSmithKline PLC | RNS |
| 25/10/17 | | 16:21:18 | 25 Oct 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 25/10/17 | | 13:00:01 | 25 Oct 2017 | | | 3rd Quarter Results | GlaxoSmithKline PLC | RNS |
| 23/10/17 | | 08:00:01 | 23 Oct 2017 | | | GSK's Shingrix Receives US FDA Approval | GlaxoSmithKline PLC | RNS |
| 20/10/17 | | 17:12:55 | 20 Oct 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/10/17 | | 17:08:54 | 20 Oct 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 16/10/17 | | 17:52:52 | 16 Oct 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 16/10/17 | | 17:42:52 | 16 Oct 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 16/10/17 | | 17:40:53 | 16 Oct 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 16/10/17 | | 17:40:19 | 16 Oct 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 16/10/17 | | 12:02:58 | 16 Oct 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 16/10/17 | | 11:57:54 | 16 Oct 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 13/10/17 | | 19:31:10 | 13 Oct 2017 | | | GSK first approval of Shingrix in Canada | GlaxoSmithKline PLC | RNS |
| 13/10/17 | | 17:25:44 | 13 Oct 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 13/10/17 | | 17:20:35 | 13 Oct 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 13/10/17 | | 12:53:50 | 13 Oct 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/10/17 | | 14:34:17 | 11 Oct 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 02/10/17 | | 11:19:32 | 2 Oct 2017 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 25/09/17 | | 15:57:01 | 25 Sept 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 20/09/17 | | 08:00:02 | 20 Sept 2017 | | | Positive IMPACT results for Trelegy in COPD | GlaxoSmithKline PLC | RNS |
| 19/09/17 | | 08:00:03 | 19 Sept 2017 | | | Trelegy Ellipta: FDA approval in COPD received | GlaxoSmithKline PLC | RNS |
| 15/09/17 | | 08:00:03 | 15 Sept 2017 | | | Trelegy Ellipta: positive opinion from CHMP Europe | GlaxoSmithKline PLC | RNS |
| 14/09/17 | | 08:00:02 | 14 Sept 2017 | | | Unanimous FDA approval for Shingrix in over 50s | GlaxoSmithKline PLC | RNS |
| 12/09/17 | | 17:07:03 | 12 Sept 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/09/17 | | 09:08:34 | 11 Sept 2017 | | | GSK announce positive results from SLS lung study | GlaxoSmithKline PLC | RNS |
| 06/09/17 | | 17:02:07 | 6 Sept 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/09/17 | | 10:43:52 | 1 Sept 2017 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 10/08/17 | | 17:43:54 | 10 Aug 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/08/17 | | 11:50:06 | 10 Aug 2017 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/08/17 | | 12:02:03 | 1 Aug 2017 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |